Holen Sie sich die Stockscreener-App
2.15
2.27%
-0.05
Handel nachbörslich:
2.32
0.17
+7.91%
Schlusskurs vom Vortag:
$2.20
Offen:
$2.44
24-Stunden-Volumen:
28.62M
Relative Volume:
1.85
Marktkapitalisierung:
$101.25M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-52.41M
KGV:
-2.3626
EPS:
-0.91
Netto-Cashflow:
$-31.25M
1W Leistung:
+20.79%
1M Leistung:
+325.74%
6M Leistung:
+99.07%
1J Leistung:
-6.93%
1-Tages-Spanne:
$2.00
$2.56
1-Wochen-Bereich:
$1.42
$2.56
52-Wochen-Spanne:
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
2.15 | 214.59M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-14 | Eingeleitet | Maxim Group | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Rani Therapeutics: Underdog to Top Performer? - StocksToTrade
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Institutional & Smart Investment Allocation Tips - newser.com
How high can Rani Therapeutics Holdings Inc. stock goMarket Growth Report & Community Consensus Stock Picks - newser.com
Will Rani Therapeutics Holdings Inc. stock attract more institutional investors - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationMarket Rally & Smart Money Movement Tracker - newser.com
Will Rani Therapeutics Holdings Inc. bounce back from current supportBuy Signal & Community Verified Watchlist Alerts - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionCEO Change & Verified Short-Term Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthDividend Hike & Weekly High Return Stock Forecasts - newser.com
MSN Money - MSN
Multi asset correlation models including Rani Therapeutics Holdings Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 20252025 Top Decliners & Consistent Return Investment Signals - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.Chart Signals & Community Trade Idea Sharing Platform - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Rani Therapeutics’ Strategic Partnerships Elevate Market Presence - timothysykes.com
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential - MSN
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - MSN
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Rani Therapeutics Holdings, Inc. (RANI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Rani Therapeutics Holdings, Inc. (RANI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times
Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan
Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com
Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat
Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - MSN
Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener
Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):